InChI=1S/C58H104F3NO9/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-25-26-27-29-31-33-35-37-39-52(65)62-49(53(66)50(64)38-36-34-32-30-28-16-14-12-10-8-6-4-2)46-70-57-55(68)54(67)56(51(44-63)71-57)69-45-47-40-42-48(43-41-47)58(59,60)61/h40-43,49-51,53-57,63-64,66-68H,3-39,44-46H2,1-2H3,(H,62,65)/t49-,50+,51+,53-,54+,55+,56-,57-/m0/s1 |
HWUZATREPHXBRD-VSVWWTSQSA-N |
O([C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)OCC=2C=CC(=CC2)C(F)(F)F)O)O)C[C@@H]([C@@H]([C@@H](CCCCCCCCCCCCCC)O)O)NC(CCCCCCCCCCCCCCCCCCCCCCCCC)=O |
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via N-acylphytosphingosine )
|
|
N-{(2S,3S,4R)-3,4-dihydroxy-1-[(4-O-{[4-(trifluoromethyl)phenyl]methyl}-α-D-galactopyranosyl)oxy]octadecan-2-yl}hexacosanamide
|
(2S,3S,4R)-1-{4-O-[4-(trifluoromethyl)benzyl]-α-D-galactopyranosyloxy}-2-hexacosanoylaminooctadecane-3,4-diol
|
ChEBI
|
N-((2S,3S,4R)-1-{4-O-[4-(trifluoromethyl)benzyl]-α-D-galactosyloxy}-3,4-dihydroxyoctadecan-2-yl)hexacosanamide
|
ChEBI
|
N-[(2S,3S,4R)-3,4-dihydroxy-1-({4-O-[4-(trifluoromethyl)benzyl]-α-D-galactopyranosyl}oxy)octadecan-2-yl]hexacosanamide
|
IUPAC
|
N-{(2S,3S,4R)-3,4-dihydroxy-1-[(4-O-{[4-(trifluoromethyl)phenyl]methyl}-alpha-D-galactopyranosyl)oxy]octadecan-2-yl}hexacosanamide
|
PDBeChem
|